NeuroOne Medical | 4:持股變動聲明-高管 Mertens Steve
NeuroOne Medical | 4:持股變動聲明-高管 Christianson Mark
NeuroOne Medical | 4:持股變動聲明-高管 Rosa David A
NeuroOne Medical | 4:持股變動聲明-高管 Mertens Steve
NeuroOne Medical | 4:持股變動聲明-高管 Christianson Mark
NeuroOne Medical | 4:持股變動聲明-高管 Rosa David A
NeuroOne Medical | 4:持股變動聲明-高管 Mertens Steve
NeuroOne Medical | 4:持股變動聲明-高管 Christianson Mark
NeuroOne Medical | 4:持股變動聲明-高管 Rosa David A
NeuroOne Medical | 4:持股變動聲明-高管 Mertens Steve
NeuroOne Medical | 4:持股變動聲明-高管 Rosa David A
NeuroOne Medical | 4:持股變動聲明-高管 Christianson Mark
NeuroOne Medical | 4:持股變動聲明-高管 Mertens Steve
NeuroOne Medical | 4:持股變動聲明-高管 McClurg Ronald W.
NeuroOne Medical | 4:持股變動聲明-高管 Christianson Mark
NeuroOne Medical | 4:持股變動聲明-高管 Rosa David A
NeuroOne Medical | SC 13G:超過5%持股股東披露文件-Nantahala Capital Management, LLC(5.1%),Wilmot B. Harkey(5.1%)等
NeuroOne Medical | 4:持股變動聲明-高管 Mertens Steve
NeuroOne Medical | 4:持股變動聲明-高管 Christianson Mark
NeuroOne Medical | 4:持股變動聲明-高管 Rosa David A
暫無數據